Condensed Consolidated Statements of Convertible Preferred Stock and Equity (Unaudited) - USD ($) $ in Thousands	Total	Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Statutory Reserve	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total Gyre Stockholders' (Deficit) Equity	Non-controlling Interest
Balance at Dec. 31, 2023	$ 13,949		$ 77	$ 68,179	$ 3,098	$ (85,538)	$ (1,644)	$ (15,828)	$ 29,777
Balance (in shares) at Dec. 31, 2023			76,595,616
Temporary Equity, Balance at Dec. 31, 2023		$ 64,525
Temporary Equity, Balance (in shares) at Dec. 31, 2023		13,151
Stock-based compensation expense	11			11				11
Stock options exercised	492			492				492
Stock options exercised (in shares)			60,297
Convertible preferred stock conversion	64,525		$ 8	64,517				64,525
Convertible preferred stock conversion (in shares)			8,767,333
Temporary Equity, Convertible preferred stock conversion		$ (64,525)
Temporary Equity, Convertible preferred stock conversion (in shares)		(13,151)
Foreign currency translation adjustments	(141)						(92)	(92)	(49)
Net income	9,935					7,532		7,532	2,403
Balance at Mar. 31, 2024	88,771		$ 85	133,199	3,098	(78,006)	(1,736)	56,640	32,131
Balance (in shares) at Mar. 31, 2024			85,423,246
Stock-based compensation expense	16			16				16
Stock options exercised	441			441				441
Stock options exercised (in shares)			114,528
Foreign currency translation adjustments	(420)						(274)	(274)	(146)
Net income	4,538					3,528		3,528	1,010
Balance at Jun. 30, 2024	93,346		$ 85	133,656	3,098	(74,478)	(2,010)	60,351	32,995
Balance (in shares) at Jun. 30, 2024			85,537,774
Stock-based compensation expense	237			237				237
Stock options exercised	374			374				374
Stock options exercised (in shares)			231,752
CVR liability settlement	29			29				29
Foreign currency translation adjustments	1,632						1,064	1,064	568
Net income	2,856					1,124		1,124	1,732
Balance at Sep. 30, 2024	98,474		$ 85	134,296	3,098	(73,354)	(946)	63,179	35,295
Balance (in shares) at Sep. 30, 2024			85,769,526
Balance at Dec. 31, 2024	98,402		$ 86	136,185	3,098	(73,453)	(2,597)	63,319	35,083
Balance (in shares) at Dec. 31, 2024			86,307,544
Stock-based compensation expense	507			507				507
Stock options exercised	956		$ 1	955				956
Stock options exercised (in shares)			1,273,931
Issuance of common stock	509			509				509
Issuance of common stock (in shares)			54,734
CVR liability settlement	25			25				25
Deferred offering costs amortization	(2)			(2)				(2)
Foreign currency translation adjustments	171						111	111	60
Net income	3,734					2,698		2,698	1,036
Balance at Mar. 31, 2025	104,302		$ 87	138,179	3,098	(70,755)	(2,486)	68,123	36,179
Balance (in shares) at Mar. 31, 2025			87,636,209
Balance at Dec. 31, 2024	$ 98,402		$ 86	136,185	3,098	(73,453)	(2,597)	63,319	35,083
Balance (in shares) at Dec. 31, 2024			86,307,544
Stock options exercised (in shares)	1,972,548
Net income	$ 11,200
Balance at Sep. 30, 2025	137,415		$ 91	167,134	3,098	(66,703)	(1,700)	101,920	35,495
Balance (in shares) at Sep. 30, 2025			90,890,381
Balance at Mar. 31, 2025	104,302		$ 87	138,179	3,098	(70,755)	(2,486)	68,123	36,179
Balance (in shares) at Mar. 31, 2025			87,636,209
Stock-based compensation expense	906			906				906
Stock options exercised	1,032		$ 1	1,031				1,032
Stock options exercised (in shares)			631,064
Issuance of common stock	23,000		$ 3	22,997				23,000
Issuance of common stock (in shares)			2,555,555
Stock insurance cost	(1,676)			(1,676)				(1,676)
Foreign currency translation adjustments	303						199	199	104
Net income	1,576					442		442	1,134
Balance at Jun. 30, 2025	129,443		$ 91	161,437	3,098	(70,313)	(2,287)	92,026	37,417
Balance (in shares) at Jun. 30, 2025			90,822,828
Stock-based compensation expense	1,147			1,147				1,147
Stock options exercised	50			50				50
Stock options exercised (in shares)			67,553
Deferred offering costs amortization	(3)			(3)				(3)
Foreign currency translation adjustments	842						587	587	255
Capital injection in a subsidiary				4,503				4,503	(4,503)
Net income	5,936					3,610		3,610	2,326
Balance at Sep. 30, 2025	$ 137,415		$ 91	$ 167,134	$ 3,098	$ (66,703)	$ (1,700)	$ 101,920	$ 35,495
Balance (in shares) at Sep. 30, 2025			90,890,381